Schering-Plough
- D07 - Preparados dermatológicos con corticosteroides
- DIPROSALIC cutaneous emulsion 0.05%+2%
- G03 - Hormonas sexuales y moduladores del sistema genital
- LIVIAL tablet 2.5 mg
- MERCILON tablet 0.15 mg+0.02 mg
- H02 - Corticosteroides para uso sistémico
- CELESTENE CHRONODOSE suspension for injection 2.7 mg/1 ml+3 mg/1 ml
- CELESTENE dispersible tablet 2 mg
- CELESTENE oral drops, solution 0.5 mg/ml
- CELESTENE solution for injection 4 mg/1 ml
- CELESTENE solution for injection 8 mg/2 ml
- DIPROSTENE suspension for injection 2 mg/1 ml+5 mg/1 ml
- J01 - Antibacterianos para uso sistémico
- NETROMICINE solution for injection 100 mg/1 ml
- NETROMICINE solution for injection 150 mg/1.5 ml
- NETROMICINE solution for injection 25 mg/1 ml
- NETROMICINE solution for injection 50 mg/2 ml
- L03 - Inmunoestimulantes
- INTRONA PEN solution for injection 18 M IU/1.5 ml
- INTRONA PEN solution for injection 30 M IU/1.5 ml
- INTRONA powder and solvent for solution for injection 1 M IU
- N06 - Psicoanalépticos
- ATHYMIL film-coated tablet 30 mg
- R06 - Antihistamínicos para uso sistémico
- CLARITYNE effervescent tablet 10 mg
- CLARITYNE tablet 10 mg
- POLARAMINE prolonged-release tablet 6 mg
- POLARAMINE syrup 0.01%
- POLARAMINE tablet 2 mg